277 related articles for article (PubMed ID: 35730647)
41. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
[TBL] [Abstract][Full Text] [Related]
42. Epigenetics and its therapeutic potential in colorectal cancer.
Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
44. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide analysis of DNA methylation identifies two CpG sites for the early screening of colorectal cancer.
Wang X; Wang D; Zhang H; Feng M; Wu X
Epigenomics; 2020 Jan; 12(1):37-52. PubMed ID: 31762318
[No Abstract] [Full Text] [Related]
46. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
47. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
Zoratto F; Rossi L; Verrico M; Papa A; Basso E; Zullo A; Tomao L; Romiti A; Lo Russo G; Tomao S
Tumour Biol; 2014 Jul; 35(7):6195-206. PubMed ID: 25051912
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of epigenetic methylation biomarkers for the detection of colorectal cancer using droplet digital PCR.
Petit J; Carroll G; Zhao J; Roper E; Pockney P; Scott RJ
Sci Rep; 2023 Jun; 13(1):8883. PubMed ID: 37264006
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review.
Xue M; Lai SC; Xu ZP; Wang LJ
J Dig Dis; 2015 Dec; 16(12):699-712. PubMed ID: 26565661
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.
Hashimoto Y; Zumwalt TJ; Goel A
Epigenomics; 2016 May; 8(5):685-703. PubMed ID: 27102979
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.
Cao Q; Tian Y; Deng Z; Yang F; Chen E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542332
[TBL] [Abstract][Full Text] [Related]
52. High potential of
Moradi K; Babaei E; Rezvani N; Safaralizadeh R; Bashiri H; Feizi MAH
Indian J Cancer; 2020; 57(2):166-171. PubMed ID: 32445320
[TBL] [Abstract][Full Text] [Related]
53. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract][Full Text] [Related]
54. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
[TBL] [Abstract][Full Text] [Related]
55. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
56. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
57. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
58. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
59. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
60. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.
Ng JM; Yu J
Int J Mol Sci; 2015 Jan; 16(2):2472-96. PubMed ID: 25622259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]